Cynthia Arbeeny

Company: Mitotherapeutix

Job title: Chief Scientific Officer

Seminars:

Treating Chronic Diseases Associated with Mitochondrial Pathophysiology with a Novel siRNA Approach 11:00 am

Demonstrated the role of MCJ, a key mitochondrial regulator, in NASH, related liver diseases, kidney and cardiovascular disease Developed a liver-targeted siRNA as a therapeutic approach to treating NASH; efficacy demonstrated in multiple preclinical disease models Conducting safety pharmacology and toxicity studies to support an IND filing with no adverse findings thus farRead more

day: Day Two